ID: MRFR/LS/0128-HCR | 60 Pages | Published By Rahul Gotadki on March 2023
Market Scenario: The Americas Sterility Testing Market is expected to reach USD 7,632.3 Million by 2030 at 10.4% CAGR during the forecast period 2022-2030. Sterility testing is one of the important aspect in the healthcare sector. It ensures the purity and safety of a product or a substance. Sterilization of the product and devices ensures the safety of the products. The major driving factor for the growth of the market are increasing manufactures of the medical devices & products, increasing prevalence of many infectious diseases, and increasing in the R&D activities. According to the Centers for Disease Control and Prevention, in 2012, about half of all adults i.e. 117 million American had one or more chronic health problem. Increasing number of diseases has intensified the research activities, which has significantly driven the market. Furthermore, technological advances, growth of pharmaceutical industries, increasing support provided by the government and increasing R&D investment have fuelled the market growth in this region. However, time consuming approval process and strict regulatory guidelines are the key factors responsible for slow the market growth, which is expected to do so over the given period.
Market Assessment
Source: World Health Organization (WHO, white paper, company presentation, annual report
Intended Audience
 The Americas sterility testing market is expected to grow at a CAGR of 9.8% during the projected period 2017-2023Â
Figure 1:- Americas sterility testing market, by products 2016 (% share)
Source: World Health Organization (WHO, white paper, company presentation, annual report Regional Analysis On the regional basis, the Americas is segmented into North America and South America. North America holds a major share of the market owing to increasing number of approval of new drugs, increasing demand for the better quality products and increasing number of healthcare organizations like hospital, private research institute has led to increase in the market in North America. America sterility testing market is segmented into the US and Canada. The US is the major contributor to the market in this region. South America shows a steady growth in the market. Key Players Some of the major player in the market are Charles River Laboratories International, Inc. (US), Avance Biosciences (US), Boston Scientific Corporation (US), Paragon Bioservices, Inc (US), Thermo Fisher Scientific, Inc. (U.S.), Avista Pharma Solutions (US), DYNALABS LLC. (US), and Merck KGaA (Germany)